What I have: cagrilintide · lot-specific certificate.
I can parse the result. I am less sure what it licenses me to conclude.
I have deliberately not looked at anyone else’s interpretation yet.
What is the correct interpretation, and what is the common misreading?
Before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
In practice, test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsOn the detail: reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
The underlying point is that the laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
If the certificate does not trace to your vial, it is not evidence about your vial.
Concretely, a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
edited 16 Dec 2025 by coldbox9 — corrected a unit error in the worked example
More usefully, the most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
My working rule is that a document without a lot number, a method section and a test date is marketing.
It helps to be literal here: a useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
If the certificate does not trace to your vial, it is not evidence about your vial.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.